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INTRODUCTION & OBJECTIVES: To evaluate the diagnostic accuracy of hexylaminolaevulinate (HAL) hydrochloride 
(Hexvix ®) PDD cystoscopy compared with standard white light cystoscopy in  an observational, open-label, 
comparative, controlled (within patient), multicenter study that used this diagnostic tool on a regular basis in daily 
practice. Sensitivity, specificity, positive predictive value and negative predictive value with each method were 
calculated.
MATERIAL & METHODS: Between January 2010 and January 2011, 96 consecutive patients with suspected or 
confirmed bladder cancer were recruited for the HeRo observational, open-label, comparative, controlled (within 
patient) study done at 5 centers in Italy. 
All patients had standard white light (WLC) followed by blue light cystoscopy (BLC). The presence and the number of 
positive lesions/suspicious areas compared to surrounding urothelium detected using  WLC and BLC were recorded. 
Biopsies/resection of each positive lesion/suspicious areas were always taken after the bladder was inspected under 
WLC and BLC.
RESULTS: Overall, 234 suspicious lesions were detected in 96 patients; 108 (46.2%) were histologically confirmed to 
be bladder tumors/CIS. The sensitivity of BLC biopsies was significantly higher than for WLC technique (p<0.00001; 
99.1% vs. 76.8%; Delta% 22.3; McNemar Test χ2 20.346). The relative sensitivity of BLC versus WLC was 1.289 (CI 
1.164-1.415) showing a superiority of BLC of 28.9% (CI 95% 16.4%-41.5%). The specificity of BLC biopsies was not 
significantly different compared to WLC (p=0.445; 36.5% vs. 30.2%; Delta% -6.3; McNemar Test χ2 0.583). Positive 
predictive value per biopsy for BLC- and WLC- guided biopsies was 54.9% and  50.9%, respectively. Negative 
predictive value per biopsy for BLC- and  WLC- guided biopsies was  97.4% and 64.8%, respectively. The false 
positive biopsy rate for BLC- and WLC- guided biopsies was 45.1% and 49.1%, respectively. The sequential design 
analysis shows that in 83 patients the correct diagnosis was reached both by WLC and by BLC. At contrary the correct 
diagnosis was reached by BLC alone and WLC alone, in 11 patients (11.5%) and in 2 patients (2%) respectively. 
Therefore BLC and WLC reached the correct diagnosis in 97.9% and in 88.5%, respectively. This difference was 
statistically significant (P=0.0265; Delta % 9.4; CI 95% 1.1- 17.7).
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CONCLUSIONS: HAL hydrochloride PDD cystoscopy used on a regular basis in daily practice enhances the 
diagnostic accuracy of standard cystoscopy with an elevate negative predictive value for BLC compared to WLC 
permitting an improvement in patient prognosis.
